Global Cell Therapy Biomanufacturing Market 2022-2028 - Market Study Report

Global Cell Therapy Biomanufacturing Market 2022-2028

Report Format: PDF | Report ID: 5419272 | Published Date: June 29, 2022

Choose License
Cell therapies aims to introduce new, healthy cells into a patient's body, to replace the diseased or missing ones. Manufacturing them involves collecting a specific set of cells from the blood, modifying them to produce a more vigorous attack on a patient's cancer cells, and then reinjecting them into the patient. The global cell therapy biomanufacturing market is likely to register a CAGR of over 8.8% with an incremental growth of USD 4 billion during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global cell therapy biomanufacturing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the cell therapy biomanufacturing industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the application, and region. The global market for cell therapy biomanufacturing can be segmented by application: bone repair, cancer, cardiovascular diseases, neurological disorders, skeletal muscle repair, others. In 2021, the skeletal muscle repair segment made up the largest share of revenue generated by the cell therapy biomanufacturing market. Cell therapy biomanufacturing market is further segmented by region: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global cell therapy biomanufacturing market in 2021.

By application:
- bone repair
- cancer
- cardiovascular diseases
- neurological disorders
- skeletal muscle repair
- others

By region:
- Asia Pacific
- Europe
- North America
- MEA (Middle East and Africa)
- Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Bone Therapeutics S.A., Caladrius Biosciences, Inc., Iovance Biotherapeutics, Inc., Lonza Group AG, Merck KGaA, Novartis AG, Regen BioPharma, Inc., Regeneus Ltd., The Bristol-Myers Squibb Company (BMS), among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global cell therapy biomanufacturing market.
- To classify and forecast the global cell therapy biomanufacturing market based on application, region.
- To identify drivers and challenges for the global cell therapy biomanufacturing market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cell therapy biomanufacturing market.
- To identify and analyze the profile of leading players operating in the global cell therapy biomanufacturing market.

Why Choose This Report
- Gain a reliable outlook of the global cell therapy biomanufacturing market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
?? Report description
?? Objectives of the study
?? Market segment
?? Years considered for the report
?? Currency
?? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
?? Introduction
?? Drivers
?? Restraints
?? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY APPLICATION
?? Bone repair
?? Cancer
?? Cardiovascular diseases
?? Neurological disorders
?? Skeletal muscle repair
?? Others
PART 6. MARKET BREAKDOWN BY REGION
?? Asia Pacific
?? Europe
?? North America
?? MEA (Middle East and Africa)
?? Latin America
PART 7. KEY COMPANIES
?? Bone Therapeutics S.A.
?? Caladrius Biosciences, Inc.
?? Iovance Biotherapeutics, Inc.
?? Lonza Group AG
?? Merck KGaA
?? Novartis AG
?? Regen BioPharma, Inc.
?? Regeneus Ltd.
?? The Bristol-Myers Squibb Company (BMS)
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

This GCC report is based on the synthesis, analysis, and interpretation of information about the global market collected from specialized sources. GCC analysts have derived insights using a mix of primary and secondary research with an aim to provide a holistic picture of the market. The research methodology used to estimate and forecast the market begins with capturing data on key players’ revenues in the market through secondary research. The bottom-up procedure was employed to obtain the overall market size of the global market. Specific to this market, global market volume & revenue is estimated on the basis of the sales information of key major players.  
 

After arriving at the overall market size, the industry is then divided into several segments and sub-segments which are then verified through primary research by conducting extensive interviews with key people such as CEOs, sales managers, Directors and executives. Drawing on GCC’s research, expert interviews, and extensive experience working with market-facing companies worldwide, main trends that have begun- and will most likely continue-to affect this industry are identified and analyzed.

Publisher: Gen Consulting Company

Budget constraint? Get in touch to get special pricing offers


Request For Discount

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us